SEHK:1066Medical Equipment
Shandong Weigao (SEHK:1066): Evaluating Valuation Following Q3 Revenue Growth and Ongoing Pricing Headwinds
Shandong Weigao Group Medical Polymer (SEHK:1066) just released its third quarter results, revealing a 3% increase in revenue compared to a year earlier. Growth was led by orthopedics, interventional products, and blood management. However, pharma packaging and medical devices felt the squeeze from government pricing policies.
See our latest analysis for Shandong Weigao Group Medical Polymer.
Shandong Weigao Group Medical Polymer’s share price has cooled off lately after a challenging month,...